MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference: Our Bureau, Mumbai Tuesday, January 7, 2025, 12:00 Hrs [IST] Biotech Showcase 2025, an ex ...
Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:30 Hrs [IST] CRIUS Group has emerged as India’s first contract manufac ...
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu: Our Bureau, Mumbai Tuesday, January 7, 2025, 11:15 Hrs [IST] As a part of its CSR vision to bring ...
Claypond Capital appoints Dr Shravan Subramanyam to lead its medical technology platform: Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:45 Hrs [IST] Claypond Capital, the fam ...
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] Indian pharma ...
CDSCO establishes Sub-Zonal Office in Bhubaneswar, boosting Odisha’s pharmaceutical sector: Shardul Nautiyal, Mumbai Tuesday, January 7, 2025, 08:00 Hrs [IST] In a significant m ...
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer: Philadelphia, Pennsylvania Tuesday, January 7, 2025, 10:00 Hrs [IST] Researche ...
Indian healthcare sees medical networking as catalyst for quality services in remote regions: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] The Indian h ...
Extension of revised Schedule M deadline fails to bring total relief to MSMEs: Gireesh Babu, New Delhi Tuesday, January 7, 2025, 08:00 Hrs [IST] Even as the Union health ministry' ...